Ying Gu

发表

Self-assembled nanoparticle drug delivery systems from galactosylated polysaccharide-doxorubicin conjugate loaded doxorubicin.

Hongxuan He, Yu Cao, Peiguang Zhao, 2010, International journal of biological macromolecules.

Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases.

L. Golub, T. Sorsa, H. Tenenbaum, 2016, International dental journal.

Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine

L. Golub, M. Ryan, C. Walker, 2012, Journal of oral microbiology.

Doxycycline [corrected] inhibits mononuclear cell-mediated connective tissue breakdown.

S. Simon, L. Golub, Hsi-Ming Lee, 2010, FEMS immunology and medical microbiology.

SAGE: Novel Therapy to Reduce Inflammation in a Naturally Occurring-Dog Model of Periodontal Disease

Hsi-Ming Lee, Ying Gu, M. Ryan, 2022, Journal of experimental pharmacology.

Therapeutic potential of a novel semi-synthetic-sulfated-polysaccharide to suppress inflammatory mediators in P. gingivalis LPS stimulated human monocytes/macrophages

G. Prestwich, Hsi-Ming Lee, M. Ryan, 2021, Journal of inflammation.

Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs

J. Scaduto, L. Golub, Hsi-Ming Lee, 2020, Journal of experimental pharmacology.

A Novel Chemically Modified Curcumin “Normalizes” Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies

L. Golub, Hsi-Ming Lee, Yazhou Zhang, 2016, Journal of diabetes research.

Doxycyline inhibits mononuclear cell-mediated connective tissue breakdown

S. Simon, L. Golub, Hsi-Ming Lee, 2010 .

Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines

Y. Konttinen, S. Simon, L. Golub, 2005, Annals of medicine.

Chemically modified tetracycline-3 (CMT-3): a novel inhibitor of the serine proteinase, elastase.

S. Simon, L. Golub, Hsi-Ming Lee, 2011, Pharmacological research.

Precise Ratiometric Control of Dual Drugs through a Single Macromolecule for Combination Therapy.

Jean Felix Mukerabigwi, Min Liu, Xueying Huang, 2015, Molecular pharmaceutics.

Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications

J. Scaduto, L. Golub, Hsi-Ming Lee, 2019, Journal of experimental pharmacology.

4-Methoxycarbonyl Curcumin: A Unique Inhibitor of Both Inflammatory Mediators and Periodontal Inflammation

L. Golub, Hsi-Ming Lee, T. Sorsa, 2013, Mediators of inflammation.

Design, synthesis and biological activity of new polyenolic inhibitors of matrix metalloproteinases: a focus on chemically-modified curcumins.

L. Golub, Hsi-Ming Lee, Ying Gu, 2012, Current medicinal chemistry.

The Maximum-Tolerated Dose and Pharmacokinetics of a Novel Chemically Modified Curcumin in Rats

L. Golub, Hsi-Ming Lee, Ying Gu, 2022, Journal of experimental pharmacology.

Microbial Carriage State of Peripheral Blood Dendritic Cells (DCs) in Chronic Periodontitis Influences DC Differentiation, Atherogenic Potential

C. Cutler, C. Genco, Ying Gu, 2012, The Journal of Immunology.

P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility

Ming Sun, Song Wu, Ying Gu, 2015, BMC Genetics.

Therapeutic potential of a novel semi-synthetic-sulfated-polysaccharide to suppress inflammatory mediators in P. gingivalis LPS stimulated human monocytes/macrophages

Hsi-Ming Lee, M. Ryan, Ying Gu, 2021, Journal of Inflammation.

Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss

L. Golub, Hsi-Ming Lee, Ying Gu, 2023, Journal of inflammation research.

A Novel Chemically-Modified Curcumin 2.24: Short-Term Systemic Therapy for Natural Periodontitis in Dogs

J. Scaduto, L. Golub, Hsi-Ming Lee, 2021, Frontiers in Dental Medicine.

Impact of Multidisciplinary Team Management on the Survival Rate of Head and Neck Cancer Patients: A Cohort Study Meta-analysis

Ying Gu, Linfei Feng, Jun Hou, 2021, Frontiers in Oncology.

Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation.

M. Slepian, L. Golub, Hsi-Ming Lee, 2011, Pharmacological research.

A Novel Modified-Curcumin Promotes Resolvin-Like Activity and Reduces Bone Loss in Diabetes-Induced Experimental Periodontitis

L. Golub, Hsi-Ming Lee, Ying Gu, 2021, Journal of inflammation research.

P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility

W. Hou, Ming Sun, Song Wu, 2015, BMC Genetics.

Reversion of Multidrug Resistance Using Self-Organized Nanoparticles Holding Both Doxorubicin and Targeting Moiety

Changjiang Yang, Yu Cao, Peiguang Zhao, 2010 .

Systemic review of the prevention of pit and fissure caries of permanent molars by resin sealants in children in China

Ming Sun, Ying Gu, Jun Hou, 2017, Journal of Investigative and Clinical Dentistry.

A Novel Chemically-Modified Curcumin 2.24: Short-term Systemic Treatment for Natural Periodontitis in Dogs

J. Scaduto, L. Golub, Hsi-Ming Lee, 2020 .

A novel modified-curcumin 2.24 resolves inflammation by promoting M2 macrophage polarization

Hsi-Ming Lee, Ying Gu, F. Johnson, 2023, Scientific reports.

A Novel Chemically Modified Curcumin “Normalizes” Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies

L. Golub, Hsi-Ming Lee, Yazhou Zhang, 2016, Journal of diabetes research.

A Novel Chemically Modified Curcumin “Normalizes” Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies

L. Golub, Hsi-Ming Lee, Yazhou Zhang, 2016, Journal of diabetes research.